118 related articles for article (PubMed ID: 11733339)
1. Thallum-201 single-proton emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck.
O'Tuama LA; Young Poussaint T
AJNR Am J Neuroradiol; 2001; 22(10):1983-4. PubMed ID: 11733339
[No Abstract] [Full Text] [Related]
2. Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck.
Mukherji SK; Gapany M; Phillips D; Neelon B; O'Brien S; McCartney W; Buejenovich S; Parekh JS; Noordzij JP; Castillo M
AJNR Am J Neuroradiol; 1999 Aug; 20(7):1215-20. PubMed ID: 10472974
[TBL] [Abstract][Full Text] [Related]
3. Thallium-201 SPECT in the diagnosis of head and neck cancer.
Valdés Olmos RA; Balm AJ; Hilgers FJ; Koops W; Loftus BM; Tan IB; Muller SH; Hoefnagel CA; Gregor RT
J Nucl Med; 1997 Jun; 38(6):873-9. PubMed ID: 9189132
[TBL] [Abstract][Full Text] [Related]
4. Thallium-201 single-photon emission CT in recurrent squamous cell carcinoma of the head and neck.
O'Tuama LA; Poussaint TY
AJNR Am J Neuroradiol; 2002 Jan; 23(1):174-5. PubMed ID: 11827893
[No Abstract] [Full Text] [Related]
5. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
6. The "third-best" strategy for treating head and neck cancer.
Mancuso AA
AJNR Am J Neuroradiol; 1999 Aug; 20(7):1191-2. PubMed ID: 10472968
[No Abstract] [Full Text] [Related]
7. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
8. Comparison of thallium-201 SPET and CT/MRI in the detection of residual/recurrent squamous cell carcinoma of the oral cavity.
Lee JK; Tyan YS; Huang WS
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):528-31. PubMed ID: 14722682
[TBL] [Abstract][Full Text] [Related]
9. [Role of positron emission tomography and CT with 18F-FDG PET-CT in follow-up of patients treated for head and neck squamous cell carcinoma].
Rivière D; Morvan JB; Fakhry N; Vatin L; Cathelinaud O; Bousquet F; Giovanni A; Verdalle P
Rev Laryngol Otol Rhinol (Bord); 2014; 135(3):127-33. PubMed ID: 26521355
[TBL] [Abstract][Full Text] [Related]
10. Occult primary tumors of the head and neck: accuracy of thallium 201 single-photon emission computed tomography and computed tomography and/or magnetic resonance imaging.
van Veen SA; Balm AJ; Valdés Olmos RA; Hoefnagel CA; Hilgers FJ; Tan IB; Pameijer FA
Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):406-11. PubMed ID: 11296049
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of head and neck squamous cell carcinoma after treatment.
Mukherji SK; Wolf GT
AJNR Am J Neuroradiol; 2003 Oct; 24(9):1743-6. PubMed ID: 14561596
[No Abstract] [Full Text] [Related]
12. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
13. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.
Zimmer LA; Branstetter BF; Nayak JV; Johnson JT
Laryngoscope; 2005 Nov; 115(11):2029-34. PubMed ID: 16319618
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experience with thallous chloride T1 201-labeled single-photon emission computed tomography scanning in head and neck cancer.
Gregor RT; Valdés-Olmos R; Koops W; Balm AJ; Hilgers FJ; Hoefnagel CA
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):509-14. PubMed ID: 8615968
[TBL] [Abstract][Full Text] [Related]
16. Is FDG -PET-CT a valuable tool in prediction of persistent disease in head and neck cancer.
Uzel EK; Ekmekcioglu O; Elicin O; Halac M; Uzel OE
Asian Pac J Cancer Prev; 2013; 14(8):4847-51. PubMed ID: 24083757
[TBL] [Abstract][Full Text] [Related]
17. ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature.
Lauridsen JK; Rohde M; Thomassen A
PET Clin; 2015 Jan; 10(1):75-88. PubMed ID: 25455881
[TBL] [Abstract][Full Text] [Related]
18. Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.
Chen SW; Hsieh TC; Yen KY; Yang SN; Wang YC; Chien CR; Liang JA; Kao CH
Laryngoscope; 2014 Dec; 124(12):2732-8. PubMed ID: 25042474
[TBL] [Abstract][Full Text] [Related]
19. [Role of PET-CT with 18-FDG in the management of UADT squamous-cell carcinomas: a retrospective study of 43 cases].
Ricard AS; Gindre A; Laurentjoye M; Fernandez P; Guyot M; Demeaux H; Siberchicot F; Majoufre-Lefebvre C
Rev Stomatol Chir Maxillofac; 2008 Apr; 109(2):86-90. PubMed ID: 18207477
[TBL] [Abstract][Full Text] [Related]
20. Imaging of cervical lymph nodes in head and neck cancer: the basics.
Gor DM; Langer JE; Loevner LA
Radiol Clin North Am; 2006 Jan; 44(1):101-10, viii. PubMed ID: 16297684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
